Literature DB >> 24605815

Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.

Suzanne R Kalb1, Jakub Baudys, Theresa J Smith, Leonard A Smith, John R Barr.   

Abstract

Botulinum neurotoxins (BoNTs) are produced by various species of clostridia and are potent neurotoxins which cause the disease botulism, by cleaving proteins needed for successful nerve transmission. There are currently seven confirmed serotypes of BoNTs, labeled A-G, and toxin-producing clostridia typically only produce one serotype of BoNT. There are a few strains (bivalent strains) which are known to produce more than one serotype of BoNT, producing either both BoNT/A and /B, BoNT/A and /F, or BoNT/B and /F, designated as Ab, Ba, Af, or Bf. Recently, it was reported that Clostridium botulinum strain Af84 has three neurotoxin gene clusters: bont/A2, bont/F4, and bont/F5. This was the first report of a clostridial organism containing more than two neurotoxin gene clusters. Using a mass spectrometry based proteomics approach, we report here that all three neurotoxins, BoNT/A2, /F4, and /F5, are produced by C. botulinum Af84. Label free MS(E) quantification of the three toxins indicated that toxin composition is 88% BoNT/A2, 1% BoNT/F4, and 11% BoNT/F5. The enzymatic activity of all three neurotoxins was assessed by examining the enzymatic activity of the neurotoxins upon peptide substrates, which mimic the toxins' natural targets, and monitoring cleavage of the substrates by mass spectrometry. We determined that all three neurotoxins are enzymatically active. This is the first report of three enzymatically active neurotoxins produced in a single strain of Clostridium botulinum.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24605815      PMCID: PMC4522913          DOI: 10.1021/ac5001509

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

1.  Quantification of proteins using data-independent analysis (MSE) in simple andcomplex samples: a systematic evaluation.

Authors:  Yishai Levin; Eva Hradetzky; Sabine Bahn
Journal:  Proteomics       Date:  2011-07-13       Impact factor: 3.984

2.  Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.

Authors:  G Schiavo; O Rossetto; S Catsicas; P Polverino de Laureto; B R DasGupta; F Benfenati; C Montecucco
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

3.  Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.

Authors:  J Blasi; E R Chapman; E Link; T Binz; S Yamasaki; P De Camilli; T C Südhof; H Niemann; R Jahn
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

4.  Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins.

Authors:  Suzanne R Kalb; Jakub Baudys; Christina Egan; Theresa J Smith; Leonard A Smith; James L Pirkle; John R Barr
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

5.  Sequence diversity of genes encoding botulinum neurotoxin type F.

Authors:  Brian H Raphael; Mallory J Choudoir; Carolina Lúquez; Rafael Fernández; Susan E Maslanka
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

6.  Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters.

Authors:  Brian H Raphael; Carolina Luquez; Loretta M McCroskey; Lavin A Joseph; Mark J Jacobson; Eric A Johnson; Susan E Maslanka; Joanne D Andreadis
Journal:  Appl Environ Microbiol       Date:  2008-05-23       Impact factor: 4.792

7.  Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds.

Authors:  G Schiavo; A Santucci; B R Dasgupta; P P Mehta; J Jontes; F Benfenati; M C Wilson; C Montecucco
Journal:  FEBS Lett       Date:  1993-11-29       Impact factor: 4.124

8.  Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.

Authors:  Suzanne R Kalb; Consuelo Garcia-Rodriguez; Jianlong Lou; Jakub Baudys; Theresa J Smith; James D Marks; Leonard A Smith; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

9.  Botulinum neurotoxin detection and differentiation by mass spectrometry.

Authors:  John R Barr; Hercules Moura; Anne E Boyer; Adrian R Woolfitt; Suzanne R Kalb; Antonis Pavlopoulos; Lisa G McWilliams; Jurgen G Schmidt; Rodolfo A Martinez; David L Ashley
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

10.  Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.

Authors:  Suzanne R Kalb; Jianlong Lou; Consuelo Garcia-Rodriguez; Isin N Geren; Theresa J Smith; Hercules Moura; James D Marks; Leonard A Smith; James L Pirkle; John R Barr
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

View more
  14 in total

1.  A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin.

Authors:  Susan E Maslanka; Carolina Lúquez; Janet K Dykes; William H Tepp; Christina L Pier; Sabine Pellett; Brian H Raphael; Suzanne R Kalb; John R Barr; Agam Rao; Eric A Johnson
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

2.  Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.

Authors:  Molly S Moritz; William H Tepp; Heather N'te Inzalaco; Eric A Johnson; Sabine Pellett
Journal:  Toxicon       Date:  2019-06-07       Impact factor: 3.033

3.  Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.

Authors:  Kwok-Ho Lam; Stefan Sikorra; Jasmin Weisemann; Hannah Maatsch; Kay Perry; Andreas Rummel; Thomas Binz; Rongsheng Jin
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

4.  Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).

Authors:  Suzanne R Kalb; Jakub Baudys; Brian H Raphael; Janet K Dykes; Carolina Lúquez; Susan E Maslanka; John R Barr
Journal:  Anal Chem       Date:  2015-03-17       Impact factor: 6.986

5.  Detection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS.

Authors:  Suzanne R Kalb; Joan C Krilich; Janet K Dykes; Carolina Lúquez; Susan E Maslanka; John R Barr
Journal:  J Agric Food Chem       Date:  2015-01-22       Impact factor: 5.279

6.  Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.

Authors:  Suzanne R Kalb; Jakub Baudys; Dongxia Wang; John R Barr
Journal:  Toxins (Basel)       Date:  2015-05-19       Impact factor: 4.546

7.  Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

Authors:  Skadi Kull; K Melanie Schulz; Jasmin Weisemann; Sebastian Kirchner; Tanja Schreiber; Alexander Bollenbach; P Wojtek Dabrowski; Andreas Nitsche; Suzanne R Kalb; Martin B Dorner; John R Barr; Andreas Rummel; Brigitte G Dorner
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.

Authors:  Sabine Pellett; William H Tepp; Marite Bradshaw; Suzanne R Kalb; Janet K Dykes; Guangyun Lin; Erin M Nawrocki; Christina L Pier; John R Barr; Susan E Maslanka; Eric A Johnson
Journal:  mSphere       Date:  2016-02-24       Impact factor: 4.389

9.  Evolution of Chromosomal Clostridium botulinum Type E Neurotoxin Gene Clusters: Evidence Provided by Their Rare Plasmid-Borne Counterparts.

Authors:  Andrew T Carter; John W Austin; Kelly A Weedmark; Michael W Peck
Journal:  Genome Biol Evol       Date:  2016-03-02       Impact factor: 3.416

10.  Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.

Authors:  Suzanne R Kalb; Jakub Baudys; John R Barr
Journal:  BMC Microbiol       Date:  2015-10-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.